MedTech Spectrum

Article Name Medical Devices

Transasia Bio-Medicals retains No 1 position in Medical Devices and Diagnostics Industry Survey 2022

Revenues considered for the analysis are Medical Devices and Diagnostics sales figures in FY 21-22

11th April, 2023

Younger generation propels 15% CAGR of Indian Medical Devices Industry

Age group of consumers purchasing medical devices has shifted from primarily seniors to a much younger demographic

06th March, 2023

Industry seeks establishment of medical devices consortium from government

A panel discussion held on 'Medical Devices: A story from India' at the 10th International Conference on Transforming Healthcare with Information Technology on 13th Feb

15th February, 2023

"Financial incentives to encourage production of high-end medical devices not addressed": Healthwatch

Dr S Senthil Kandeepan, MD and CEO, Healthwatch shares his reaction on Union Budget 2023-24

03rd February, 2023

"Disheartened with no impactful announcements for encouraging Make in India Medical Devices": AiMED

Rajiv Nath, Forum Coordinator, Association of Indian Medical Device Industry (AiMeD) shares his reaction on Union Budget 2023-24

01st February, 2023

“We are more than hopeful and positive that the govt will act upon for separate dept of medical devices”

The medical devices sector has been campaigning with the government for a separate department and things seem to head towards the right direction. Rajiv Nath, Forum Coordinator, Association of Indian Medical Device Industry (AIMED) reveals more about the growth of the medical devices sector in coming years in an interaction with BioSpectrum India. Edited excerpts;

30th November, 2022

Pharmaceuticals & medical devices converge at Chitra Institute in Thiruvananthapuram

Combined Devices Block opens at Chitra Triunal Institute of Medical Science and Technology in Thiruvananthapuram

15th November, 2022

RRCAT partners with BD India to roll out first batch of sterilised medical devices

BD exploring benefits for Venflon Pro, for the Indian market and to use the facility for global supplies as well

20th October, 2022

Max Ventilator rolls out new intelligent medical devices

Innovative pulse oxymeter, monitors, and ECG among newly launched devices

14th October, 2022

Govt approves establishment of Exports Promotion Council for medical devices

The Chairman & Vice Chairman of the Council shall be elected from members who are manufacturers or processors of medical devices

22nd September, 2022

Fujifilm India to install latest medical devices at hospitals owned by Paras Healthcare

Screening devices and cutting-edge machines will be installed

23rd August, 2022

AiMeD writes to PM for separate medical devices dept

Urges name change from Department of Pharmaceuticals (DoP) to Department of Pharmaceuticals & Medical Devices

05th August, 2022

IIT-G establishes CoE for innovation & commercialisation of biomedical devices

The Centre of Excellence is presently situated at the Centre of Nanotechnology and Jyoti and Bhupat Mehta School of Health Sciences and Technology of IIT Guwahati

01st August, 2022

Health ministry proposes new draft guidelines for Drugs, Medical Devices and Cosmetics Bill, 2022

Calls for suggestions, comments and objections from various stakeholders

01st August, 2022

IIT-H announces Chair Professorship in medical devices, diagnostics

The Institute considers stalwarts in academics and industry for this chair professorship

05th May, 2022

Pharma & Medical Devices Conference 2022 to draft plan for next 25 years

Health Minister Dr Mansukh Mandaviya inaugurates the 7th International conference on Pharma and Medical Devices sector

25th April, 2022

Roche Gets FDA Clearance for Additional Alzheimer's CSF Assays, Enhancing Diagnosis and Treatment Decisions

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that its Elecsys® beta-Amyloid (1-42) CSF II (Abeta42) and Elecsys® Total-Tau CSF assays (tTau) have received U.S. Food and Drug Administration (FDA) 510(k) clearance. The Elecsys AD CSF Abeta42 and tTau assays (used as a tTau/Abeta42 ratio) measure two biomarkers of Alzheimer's pathology, beta-amyloid and tau proteins, in adults ages 55 and older being evaluated for the disease.

28th June, 2023

INVO Receives 510(k) FDA Clearance for Expanded Use of the INVOcell Device

INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its INVOcell® medical device and the intravaginal culture ("IVC") procedure it enables, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to expand the labeling on the INVOcell device and its indication for use to provide for a 5-day incubation period. The data supporting the expanded 5-day incubation clearance demonstrated improved patient outcomes.

28th June, 2023